JAZZ

Jazz Pharmaceuticals Plc

• Simply Wall St·1d ago

  Does New Epidiolex Behavioral Data at AAN 2026 Reframe Jazz Pharmaceuticals’ (JAZZ) Neuroscience Strategy?

• TipRanks·1d ago

  Nike downgraded, IBM initiated: Wall Street’s top analyst calls

• TipRanks·1d ago

  Jazz Pharmaceuticals resumed with an Outperform at Raymond James

• Reuters·1d ago

  JAZZ PHARMACEUTICALS PLC <JAZZ.O>: RAYMOND JAMES RESUMES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $227

• Reuters·1d ago

  U.S. RESEARCH ROUNDUP-Chevron, Littelfuse, Parker-Hannifin

• Benzinga·2d ago

  Jazz Pharma To Present Research On Epidiolex And Xywav Oral Solution At 2026 AAN Annual Meeting

• Reuters·2d ago

  Jazz reports EpiCom analysis shows Epidiolex cuts behavioral problems in TSC seizures

• PR Newswire·2d ago

  Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution at the 2026 American Academy of Neurology Annual Meeting

• TipRanks·2d ago

  Jazz Pharmaceuticals (JAZZ) Gets a Buy from Wells Fargo

• TipRanks·3d ago

  RBC Capital Remains a Buy on Jazz Pharmaceuticals (JAZZ)

• Seeking Alpha·5d ago

  Zai Lab: Xacduro And ZL-1310 Drive Growth Narrative

• Reuters·04/03 21:10

  Jazz director Bruce C. Cozadd disposes of Jazz Pharma shares worth $1.1 million

• NASDAQ·04/03 15:30

  Why Is Keros Therapeutics (KROS) Up 2.5% Since Last Earnings Report?

• Reuters·04/01 20:16

  Jazz Pharmaceuticals to present at Needham Virtual Healthcare Conference

• PR Newswire·04/01 20:15

  Jazz Pharmaceuticals to Participate in Needham Virtual Healthcare Conference